Atraverse Medical
Chicago, US · Founded 2022 · Delaware corporation · 36 employees on LinkedIn · 1 known investors
Find your way into Atraverse Medical
74 people in our graph share verified history with the Atraverse Medical team — schools, employers, funds. One of them is your warm intro.
David Greenwaldunlockedknows Steven Mickelsen · together at Howard Hughes Medical Institute (overlapped)
knows the team · via The University of New Mexico School of Medicine
knows the team · via The University of Iowa Hospitals and Clinics
knows the team · via Atraverse Medical
×2knows the team · via Mayo Clinic Alix School of Medicine
×3knows the team · via Howard Hughes Medical Institute
Atraverse Medical develops flexible transseptal access technologies for left-heart catheter procedures, including an RF-guidewire enabled puncture device that supports a Zero Exchange workflow. Its products are aimed at physicians performing catheter-based cardiac interventions.
Founders & leadership
Atraverse Medical was founded in 2022 by Steven Mickelsen.
SM
Steven MickelseninFounder · Board MemberSteven Mickelsen is Director at Atraverse Medical, where he works on transseptal access technologies for cardiac catheterization procedures. He has focused on developing medical devices for heart rhythm and cardiovascular conditions, with experience spanning preclinical development and clinical cardiology.
JR
John R SlumpinCEO/President & Co-Founder2022–2026
Board
ES
Eric SauterBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$33.1M disclosed across 5 rounds · 2023–2025
▶$8.6MraisedMay 2025 · 41 investors · Other Health CareRule 506(b)
▶$8.6MraisedMay 2025 · 41 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric D. SauterExecutive Officer, Director, Promoter
- John R. SlumpExecutive Officer, Director, Promoter
- Steven MickelsenExecutive Officer, Director, Promoter
- Offering amount
- $10M
- Amount sold
- $8.6M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$15MraisedFeb 2025 · 1 investors · Other Health CareRule 506(b)
▶$15MraisedFeb 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric D. SauterExecutive Officer, Director, Promoter
- John R SlumpExecutive Officer, Director, Promoter
- Steven R. MickelsenExecutive Officer, Director, Promoter
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$4.1MraisedAug 2024 · 33 investors · Other Health CareRule 506(b)
▶$4.1MraisedAug 2024 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric SauterDirector
- Steven MickelsenDirector
- John R SlumpExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4.1M
- Minimum investment
- $10K
- Proceeds to insiders
- $750K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$5MraisedNov 2023 · 32 investors · Other Health CareRule 506(b)
▶$5MraisedNov 2023 · 32 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric SauterDirector
- John R SlumpExecutive Officer, Director
- Steven MickelsenDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $100K
- Proceeds to insiders
- $1M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$400KraisedNov 2023 · 1 investors · Other Health CareRule 506(b)
▶$400KraisedNov 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John R SlumpExecutive Officer, Director
- Eric SauterDirector
- Steven MickelsenDirector
- Offering amount
- $3M
- Amount sold
- $400K
- Minimum investment
- $100K
- Proceeds to insiders
- $500K
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Atraverse Medical do?
- Atraverse Medical develops flexible transseptal access technologies for left-heart catheter procedures, including an RF-guidewire enabled puncture device that supports a Zero Exchange workflow. Its products are aimed at physicians performing catheter-based cardiac interventions.
- Who founded Atraverse Medical?
- Atraverse Medical was founded by Steven Mickelsen in 2022.
- Who are Atraverse Medical's investors?
- Atraverse Medical's investors include Band of Angels.
- How much funding has Atraverse Medical raised?
- Atraverse Medical has disclosed $33.1M raised across 5 rounds.
- Where is Atraverse Medical headquartered?
- Atraverse Medical is headquartered in Chicago, US.